Clinical Effect of Laparoscopic Radical Surgery Combined with Neoadjuvant Chemotherapy in Treating Cervical Cancer and Its Influence on Postoperative Complications and Adverse Reaction Rates.

BACKGROUND

Cervical cancer, the only gynecological malignancy for which a clear pathogeny has been established, has an incidence rate only second to breast cancer.

OBJECTIVE

In our study, we aim to investigate the clinical effect of laparoscopic radical surgery combined with neoadjuvant chemotherapy in treating cervical cancer and its influence on postoperative complications and adverse reaction rates.

METHODS

Cervical cancer patients admitted to our hospital from August 2018 to May 2020 were retrospectively analyzed as the research object and divided into the control group and the experimental group by the draw method, with 50 cases in each group. The laparoscopic radical surgery was performed on the control group, and the laparoscopic radical surgery combined with neoadjuvant chemotherapy was performed on the experimental group to compare their effective rates, adverse reaction rates, postoperative complication rates, expression levels of serum tumor necrosis factor- (TNF-) and soluble interleukin-2 receptor (SIL-2R) inside the body before surgery and at one week after surgery, quality of life (QLI) scores, and Mental Status Scale in Nonpsychiatric Settings (MSSNS) scores.

RESULTS

Compared with the control group, the experimental group obtained significantly higher effective rate and QLI scores ( < 0.05) and significantly lower adverse reaction rates, postoperative complication rates, expression levels of serum TNF- and SIL-2R inside the body at one week after surgery, and MSSNS scores ( < 0.05), with statistical differences; before surgery, the TNF- and SIL-2R expression levels of the two groups were not significantly different ( > 0.05), but the levels at one week after surgery were significantly lower than those before, indicating statistical significance ( < 0.05).

CONCLUSION

The clinical effect of laparoscopic radical surgery combined with neoadjuvant chemotherapy can obviously improve the effective rate of cervical cancer patients and lower the incidence rates of postoperative complications and adverse reactions.